Seagen Stock Price. Everything You Need To Know About The Seagen Stock!

Seagen Inc. is a biotechnology company headquartered in Bothell, Washington, that specializes in the development and commercialization of targeted therapies for the treatment of cancer. They have around 3,256 full-time employees and went IPO on 2001-03-07.

The company has a strong premarket presence in the biotechnology industry and their stocks share price today is one to watch. They are engaged in commercializing several targeted therapies, including ADCETRIS, PADCEV, TUKYSA, and TIVDAK. ADCETRIS is used for the treatment of certain CD30-expressing lymphomas, PADCEV for the treatment of certain metastatic urothelial cancers, TUKYSA for the treatment of certain metastatic HER2-positive breast and colorectal cancers, and TIVDAK for the treatment of certain metastatic cervical cancers.

Seagen Inc. is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients. They utilize their antibody-drug conjugate (ADC) technology that delivers cell-killing agents directly to cancer cells using monoclonal antibodies. This innovative approach allows them to provide targeted therapies that minimize the impact on healthy cells and improve patient outcomes.

For investors looking for a biotechnology company to consider, Seagen Inc. is an excellent option. With a commitment to improving cancer treatment outcomes, their market cap is impressive, and their dedication to innovation and developing novel therapies has helped them to establish a leading position in the market. Their stocks share price today is one to watch, and they are sure to continue making strides in the biotechnology industry.

Seagen Stock Price. Everything You Need To Know About The Seagen Stock! performance

Employees
3256
Company HQ
Bothell
Website
https://www.seagen.com/
Asset Type
Market Capitalization
0
Earnings Per Share
Dividends Per Share
Dividend Date
Quarterly Earnings Growth

Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to expand your investment portfolio? Look no further than Seagen, an exciting stock that you can invest in through the Zorion platform. Seagen is a leading biotechnology company that focuses on developing therapies for cancer treatment. With its innovative approach and groundbreaking research, Seagen has become a frontrunner in the industry. But how can you invest in Seagen from your country? Zorion provides you with the opportunity to invest in real US stocks like Seagen. With our investment insights and recommendations, you can make informed decisions about your investments. Additionally, our platform offers resources and educational materials to help you enhance your investment knowledge. Take advantage of this opportunity and start investing in Seagen today!